Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cholesterol-Lowering Program
Brain Injury Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
6-Apr-2020
Nyrada Newsletter Released
16-Mar-2020
Update on Progress in Nyrada Programs
27-Feb-2020
Nyrada Inc. Corporate Presentation February 2020
25-Feb-2020
Appendix 4D and Half Year Accounts
11-Feb-2020
Significant advance in Nyrada PCSK9i program published
20-Jan-2020
Nyrada Inc - Chairman's letter to shareholders
20-Jan-2020
Becoming a substantial holder
17-Jan-2020
Nyrada Inc - Corporate Presentation
16-Jan-2020
NOX: Listing of Nyrada Inc. spin-off on ASX
16-Jan-2020
NYR Commences Trading on the ASX
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
Next
